TAS-108
Chemical compound / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about TAS-108?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
TAS-108, also known as SR-16234, is a drug discovered by Masato Tanabe and under development by SRI International and Taiho Pharmaceutical. It is a steroid hormone that has shown signs of treating and preventing breast cancer, even in patients where tamoxifen has failed.[2][3]
Quick Facts Clinical data, Other names ...
Clinical data | |
---|---|
Other names | 17β-[2-[4-[(diethylamino)methyl]-2-methoxyphenoxy]ethyl]-7α-methylestra-1,3,5(10)-trien-3-ol; 17β-[2-[4-[(diethylamino)methyl]-2-methoxyphenoxy]ethyl]-7α-methylestradiol |
Routes of administration | By mouth[1] |
ATC code | |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII |
|
Chemical and physical data | |
Formula | C33H47NO3 |
Molar mass | 505.743 g·mol−1 |
3D model (JSmol) |
|
| |
|
Close